Hepatitis: all 3,372 studies
Page 30 of 34. Open to participants first (195), then studies with results posted, then the rest; newest registration first within each.
- Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young AdultsStatus unknownNCT00702663
- FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver TransplantationStatus unknownNCT00701272
- Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis PatientsCompletedNCT00699231Phase 1
- Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 yCompletedNCT00698906Phase 2
- Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 yCompletedNCT00698555Phase 2
- Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-BCompletedNCT00698087Phase 3
- Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15yCompletedNCT00698061Phase 3
- Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B VaccineCompletedNCT00697970Phase 3
- Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-RespondersCompletedNCT00697931Phase 3
- Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as ControlCompletedNCT00697866Phase 3
- Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy AdultsCompletedNCT00697853Phase 2
- Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-BCompletedNCT00697840Phase 3
- Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy AdolescentsCompletedNCT00697775Phase 2
- Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 GenotypeCompletedNCT00697749Phase 3
- Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of AgeCompletedNCT00697554Phase 3
- Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older AdultsCompletedNCT00697242Phase 3
- Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different SchedulesCompletedNCT00697229Phase 2
- Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).CompletedNCT00697216Phase 3
- Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different AdjuvantsCompletedNCT00697125Phase 2
- Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15yCompletedNCT00696917Phase 3
- Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in AdultsCompletedNCT00696891Phase 3
- A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXACompletedNCT00693186Phase 3
- Acute Viral Hepatitis and Diabetes MellitusStatus unknownNCT00689546
- Safety Study of SPC3649 in Healthy MenCompletedNCT00688012Phase 1
- NIDDM and IR in Combination Therapy for CHCCompletedNCT00687999Not applicable
- Mycophenolate vs Azathioprin in Autoimmune HepatitisCompletedNCT00687180Phase 4
- Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in NonrespondersCompletedNCT00684268Phase 2
- Evaluation of Neurocognitive Performance in Drug Substituted Patients Under Hepatitis C TherapyWithdrawnNCT00682591
- Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral TreatmentCompletedNCT00680342Phase 2
- Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 PatientsCompletedNCT00680173Phase 4
- Phase IV Interchangeability Study of a Liquid Pentavalent Combination VaccineCompletedNCT00674908Phase 4
- Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver TransplantationCompletedNCT00668369Phase 2
- A Single Ascending Dose Study of BMS-791325 in HCV Infected SubjectsCompletedNCT00664625Phase 1/2
- Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related CirrhosisStatus unknownNCT00663182Phase 4
- High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4TerminatedNCT00662220Phase 3
- Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)Status unknownNCT00662194
- ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis BCompletedNCT00661076Phase 3
- A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected PatientsStatus unknownNCT00660361
- Hepatitis C Treatment and AtherosclerosisCompletedNCT00659256
- A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3CompletedNCT00656006Phase 2
- Prevention of Depression in HIV/HCV Co-infected Substance Abuse PatientsTerminatedNCT00655226Not applicable
- A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)CompletedNCT00651209Phase 4
- Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis BCompletedNCT00646503Phase 4
- CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation StudyCompletedNCT00645736
- Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBVCompletedNCT00645294Phase 1/2
- PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant PatientsCompletedNCT00644761Phase 2
- Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis CCompletedNCT00643695Not applicable
- Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and RibavirinTerminatedNCT00641654Phase 4
- A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver FunctionCompletedNCT00641082Phase 4
- Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With TelbivudineCompletedNCT00640588Phase 3
- Prevention of Graft Reinfection After Liver Transplantation With Anti HCV Monoclonal Antibodies Identified in Chronically Infected Patients or in Patients With Resolved Hepatitis CStatus unknownNCT00638144
- Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNACompletedNCT00637663Phase 4
- Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With VasopressinStatus unknownNCT00635310Not applicable
- Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis CWithdrawnNCT00633230Phase 1
- Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular CarcinomaCompletedNCT00630084Phase 4
- A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 PatientsCompletedNCT00629967Phase 4
- Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis CCompletedNCT00629824Phase 4
- Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular CarcinomaCompletedNCT00629486Not applicable
- Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNACompletedNCT00625560Phase 4
- Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNACompletedNCT00625339Phase 4
- Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 NonrespondersCompletedNCT00624325Phase 2/3
- Safety and Immunogenicity Study of a Liquid Pentavalent Combination VaccineCompletedNCT00617812Phase 4
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.CompletedNCT00614471Phase 4
- Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Genotype 1 and/or 4CompletedNCT00612755Phase 4
- Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCVStatus unknownNCT00611819Phase 4
- HIV and Hepatitis Care Coordination in Methadone TreatmentCompletedNCT00608192Not applicable
- FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral TherapyCompletedNCT00606528
- Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis BWithdrawnNCT00606099Phase 4
- Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in AdultsCompletedNCT00603252Phase 4
- Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide VaccineCompletedNCT00602784Phase 2
- Psychoeducation for Hepatitis and Alcohol BehaviorsCompletedNCT00598416Not applicable
- Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis BStatus unknownNCT00597259Phase 4
- Chronic Hepatitis Intervention Project for Drug UsersCompletedNCT00596843Phase 3
- MRI to Measure Liver Fat ContentCompletedNCT00594412Not applicable
- Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis CCompletedNCT00593151Phase 1/2
- Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune HepatitisWithdrawnNCT00587119Not applicable
- Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase LevelsStatus unknownNCT00575627Phase 4
- Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9CompletedNCT00575224Phase 4
- Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive PatientsWithdrawnNCT00571714Not applicable
- Study of CTS-1027 in Hepatitis C PatientsCompletedNCT00570336Phase 2
- Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus InfectionCompletedNCT00565539Phase 1
- Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom)CompletedNCT00564811Not applicable
- A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated CirrhosisCompletedNCT00562783Phase 2
- The Effect of Adding Metformin to the Treatment of Hepatitis CCompletedNCT00560690Phase 4
- A Single Ascending Dose Study of BMS-650032 in HCV Infected SubjectsCompletedNCT00559247Phase 1/2
- Long-term Study With ClevudineCompletedNCT00558818Phase 4
- Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B PatientsCompletedNCT00558493Phase 4
- Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy AdultsCompletedNCT00557583Phase 1
- Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected PatientsCompletedNCT00553930Phase 4
- Use of Omega-3 Fatty Acids (Fish Oil) in Patients With Chronic Hepatitis C InfectionWithdrawnNCT00547716Not applicable
- Treatment Insulin Resistence in HCV G-1 PatientCompletedNCT00546442Phase 4
- Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIVCompletedNCT00545558Phase 1
- Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in TaiwanStatus unknownNCT00543244
- Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis CCompletedNCT00540345Phase 4
- Interferon-gamma With Interferon Alpha and Ribavirin for Hepatitis C Non-respondersCompletedNCT00538811Phase 2/3
- To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)CompletedNCT00537537Phase 4
- Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A VaccineCompletedNCT00534885Phase 4
- Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVRCompletedNCT00532701Phase 4
- Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis BCompletedNCT00531167Phase 4
- Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous TherapiesCompletedNCT00530972Phase 4